News|Articles|April 15, 2014

Pharmaceutical Technology

  • Pharmaceutical Technology-04-15-2014
  • Volume 2014 eBook
  • Issue 1

A Quality-by-Design Approach to Optimize In-Process Curing of EUDRAGIT NM 30 D

Author(s)Sascha Jautze

A study investigated the influence and correlation of critical process parameters for the optimization of in-process curing.

Previous studies with EUDRAGIT NM 30 D showed that storage stability can be achieved with in-process curing at specific conditions. The aim of this study was to identify and investigate the influence and correlation of critical process parameters for the optimization of in-process curing.

Download

Pharmaceutical Technology’s 2014 Solid Dosage and Excipients eBook

.

 

 

 

 

 

 

 

Articles in this issue

almost 12 years ago

Safety by Design—Mitigating the Risk of Medication Errors Through Product Design

almost 12 years ago

Controlled-Release Technologies Create Opportunities for Solid-Dosage Drug Formulators

almost 12 years ago

Continuous Manufacturing for Solid-Dosage Drug Production

almost 12 years ago

A Practical Guide to Hot-Melt Extrusion Scale-Up for Pharmaceutical Applications

almost 12 years ago

Using Modular Systems in Solid-Dosage Manufacturing

almost 12 years ago

Advances in Hot-Melt Extrusion Manufacturing

almost 12 years ago

Obtaining User-Defined Particle Size Distribution Using Dry Granulation

almost 12 years ago

Selection of Excipients in Generic Formulations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content